Literature DB >> 225562

Production of plasminogen activator by human and hamster cells infected with human cytomegalovirus.

K Yamanishi, F Rapp.   

Abstract

Plasminogen activator was produced by both human embryo fibroblasts (a permissive system) and hamster embryo fibroblasts (a nonpermissive system) after exposure to human cytomegalovirus. The level of this activator was measured by using plates coated with [125I]fibrin. The production of plasminogen activator was enhanced when the human cells were exposed to human cytomegalovirus previously irradiated with UV light (5,520 to 55,200 ergs/mm2).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 225562      PMCID: PMC353464     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

1.  Synthesis of proteins and glycoproteins in cells infected with human cytomegalovirus.

Authors:  M F Stinski
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

2.  Expression of early virus functions in human cytomegalovirus infected HEL cells: effect of ultraviolet light-irradiation of the virus.

Authors:  K Hirai; F Maeda; Y Watanabe
Journal:  J Gen Virol       Date:  1978-01       Impact factor: 3.891

3.  Production of plasminogen activator by cells transformed by herpesviruses.

Authors:  M K Howett; C S High; F Rapp
Journal:  Cancer Res       Date:  1978-04       Impact factor: 12.701

4.  Effect of caffeine on the replication of nonirradiated and ultraviolet-irradiated cytomegalovirus.

Authors:  K Yamanishi; M Fogel; F Rapp
Journal:  Intervirology       Date:  1978       Impact factor: 1.763

5.  Stimulation of ornithine decarboxylase by human cytomegalovirus.

Authors:  H C Isom
Journal:  J Gen Virol       Date:  1979-02       Impact factor: 3.891

6.  Stimulation of cellular thymidine kinases by human cytomegalovirus.

Authors:  J E Estes; E S Huang
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

7.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

8.  Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.

Authors:  J K Christman; G Acs
Journal:  Biochim Biophys Acta       Date:  1974-03-27

9.  Thymidine-kinase in cytomegalovirus infected cells.

Authors:  V Závada; V Erban; D Rezácová; V Vonka
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

10.  Induction of alpha type DNA polymerases in human cytomegalovirus-infected WI-38 cells.

Authors:  K Hirai; Y Watanabe
Journal:  Biochim Biophys Acta       Date:  1976-10-18
View more
  6 in total

1.  Dissociation between cellular DNA- and histone synthesis following infection by cytomegalovirus in the presence of phosphonoacetic acid.

Authors:  K Radsak; D Weder
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

2.  Actin distribution and synthesis in human fibroblasts infected by cytomegalovirus.

Authors:  D Lösse; R Lauer; D Weder; K Radsak
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

3.  Tumorigenicity of herpesvirus-transformed cells correlates with production of plasminogen activator.

Authors:  S F Adelman; M K Howett; F Rapp
Journal:  Mol Cell Biol       Date:  1981-05       Impact factor: 4.272

4.  Human cytomegalovirus (strain AD169) contains sequences related to the avian retrovirus oncogene v-myc.

Authors:  D H Spector; J P Vacquier
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

5.  Enhanced capacity of DNA repair in human cytomegalovirus-infected cells.

Authors:  Y Nishiyama; F Rapp
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

6.  Human cytomegalovirus induces stage-specific embryonic antigen 1 in differentiating human teratocarcinoma cells and fibroblasts.

Authors:  P W Andrews; E Gönczöl; B A Fenderson; E H Holmes; G O'Malley; S Hakomori; S Plotkin
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.